All In Biotech

Drug Trial Radar · NCT05441488

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/Day Versus Placebo in the Treatment of Patients With Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

SuspendedPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Suspended

Enrollment

800

Planned (sponsor's estimate)

Start

Jun 28, 2022

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
AB ScienceIndustry
Sponsor type
Industry
First posted
Jul 1, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple sclerosis without relapse.

Conditions

  • Progressive Multiple Sclerosis

Interventions

  • PlaceboDrug

    treatment per os

  • Masitinib (4.5)Drug

    Masitinib (titration to 4.5 mg/kg/day)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to confirmed progressionTime frame: 96 weeks

Locations

37 sites in 8 countries. Site status is shown where the registry gives one.

  • Service de Neurologie Hôpital Henri-Mondor

    Créteil, France

  • Hôpital Roger Salengro

    Lille, France

  • Hôpital Pasteur - CHU de Nice

    Nice, France

  • Centre Hospitalier Universitaire Nimes - Service de Neurologie

    Nîmes, France

  • Centre hospitalier intercommunal de Poissy-Saint-Germain-en-Laye

    Poissy, France

  • Le Centre hospitalier universitaire de Poitiers

    Poitiers, France

  • Centre Hospitalier Universitaire de Rouen

    Rouen, France

  • Centre Hospitalier Universitaire de Strasbourg

    Strasbourg, France

  • Centre Hospitalier Universitaire Toulouse

    Toulouse, France

  • Athens Naval Hospital

    Athens, Greece

  • Eginition Hospital, Athens University Medical School

    Athens, Greece

  • General University Hospital of Larissa

    Larissa, Greece

  • AHEPA University Hospital, Aristotle University of Thessaloniki

    Thessaloniki, Greece

  • Private Clinic ELPIS

    Volos, Greece

  • Azienda Ospedaliero Universitaria Policlinico "G.Rodolico -San Marco"

    Catania, Italy

  • Nzoz Neuro-Medic

    Katowice, Poland

  • NOVI-MED

    Ksawerów, Poland

  • Centrum Neurologii Krzysztof Selmaj

    Lodz, Poland

  • NZOZ Neuro-Med

    Lublin, Poland

  • Generała Jarosława Dąbrowskiego

    Oświęcim, Poland

  • NZOZ Neuro-Kard

    Poznan, Poland

  • Clinical Best Solutions

    Warsaw, Poland

  • State Budgetary Institution of Health of the City of Moscow City Polyclinic #2

    Moscow, Russia

  • Perm Regional Clinical Hospital

    Perm, Russia

  • City Hospital No. 40 Kurortny District

    Saint Petersburg, Russia

  • LLC "Center of socially significant diseases"

    Saint Petersburg, Russia

  • Hospital del Mar

    Barcelona, Spain

  • Hospital Universitario de Cruces

    Bilbao, Spain

  • Gregorio Marañón General University Hospital

    Madrid, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital Universitario y Politécnico La Fe

    Valencia, Spain

  • Sahlgrenska University Hospital

    Gothenburg, Sweden

  • Centrum för neurologi

    Stockholm, Sweden

  • Lviv Regional Clinical Hospital

    Lviv, Ukraine

  • Rivne Regional Specialized Dispensary for Radiation Protection of the Population Municipal Enterprise

    Rivne, Ukraine

  • Communal Non-Profit Enterprise "Ternopil Regional Clinical Psychoneurological Hospital" of Ternopil Regional Council, Department of Neurology #1

    Ternopil, Ukraine

  • Salutem Medical Center

    Vinnytsia, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.